Nieves Martinez Lago, Specialist in the Field (FEA) of Medical Oncology at University Hospital Complex of Santiago de Compostela, shared a post by Enrique de Madaria, Gastroenterologist at Dr. Balmis General University Hospital and Independent Councillor at UEG, on X, adding:
“2015: My first paper as first author.
Not big, not landmark, not noticed.
But it changed everything.
Adjuvant CRT in GC/GEJ with infusional 5-FU (modified McDonald)
RWE: Same efficacy, better tolerability.
That’s where my path began.”
Title: Adjuvant treatment with infusional 5-fluorouracil in high risk adenocarcinoma of the stomach or gastroesophageal junction
Authors: N. Martínez-Lago, M. Vieito-Villar, Y. Vidal-Insua, M. E. Padin-Iruegas, F. Vazquez-Rivera, S. Candamio-Folgar, R. Lopez-Lopez
Quoting Enrique de Madaria‘s post:
“I still remember the first paper that truly felt like mine.
It was not a big trial. Not a landmark paper.
Not something that drew major (or minor) attention at the time.
But it started something.
Don’t miss my latest post on my blog”
Other articles featuring Nieves Martinez Lago on OncoDaily.